Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cerrato

Showing results (171-180 of 246) with videos related to

Pageof 25
Sort By:
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 22, 2025
Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsyLin Wang, Luca Paolucci, Angela McInerney, et al.
Emergency Medicine Journal : EMJ|March 17, 2021
Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registryMaurizio Bertaina, Ivan J Nuñez-Gil, Luca Franchin, et al.
International Journal of Cardiology|June 21, 2017
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysisFabrizio D'Ascenzo, Mario Iannaccone, Ovidio De Filippo, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
Pageof 25

Showing results (171-180 of 246) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 22, 2025
Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsyLin Wang, Luca Paolucci, Angela McInerney, et al.
Emergency Medicine Journal : EMJ|March 17, 2021
Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registryMaurizio Bertaina, Ivan J Nuñez-Gil, Luca Franchin, et al.
International Journal of Cardiology|June 21, 2017
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysisFabrizio D'Ascenzo, Mario Iannaccone, Ovidio De Filippo, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
Pageof 25